An economic evaluation of vasoactive agents used to treat acute bleeding oesophageal varices in Belgium

Acta Gastro-Enterologica Belgica

Volumn 71, Issue 2, 2008, Pages 230-236

  Connolly, Mark ^a   Bhatt, Aomesh ^a   Wechowski, Jaro ^b   Colle, Isabelle ^c  

^a Ferring Pharmaceuticals AS   (Denmark)

^b Pharmarchitecture Limited   (United Kingdom)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; PLACEBO; SOMATOSTATIN; TERLIPRESSIN;

ARTICLE; BELGIUM; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; ECONOMIC EVALUATION; ESOPHAGUS HEMORRHAGE; ESOPHAGUS VARICES; HEALTH CARE COST; HUMAN; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; QUALITY OF LIFE; SCLEROTHERAPY; SENSITIVITY ANALYSIS;

BELGIUM; COSTS AND COST ANALYSIS; ESOPHAGEAL AND GASTRIC VARICES; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COSTS; HUMANS; INCIDENCE; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 47149083308     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. ZAMAN A. Current management of esophageal varices. Curr. Treat. Options Gastroenterol., 2003, 6 : 499-507.
2. GRALNEK I.M., JENSEN D.M., KOVACS T.O. et al. The economic impact of esophageal variceal hemorrhage : cost-effectiveness implications of endoscopic therapy. Hepatology, 1999, 29 : 44-50.
3. KOVACS T., JENSEN D. Therapeutic endoscopy for upper gastrointestinal bleeding. In : TAYLOR M., GOLLAN J., PEPPERCORN M., STEER M., WOLFE M. (eds). Gastrointestinal Emergencies. Baltimore : Williams and Wilkins, 2006 : 181-198.
4. LAINE L. Upper gastrointestinal tract hemorrhage. West J. Med., 1991, 155 : 274-279.
5. RUBENSTEIN J.H., EISEN G.M., INADOMI J.M. A cost-utility analysis of secondary prophylaxis for variceal hemorrhage. Am. J. Gastroenterol., 2004, 99 : 1274-1288.
6. TARGOWNIK L.E., SPIEGEL B.M., DULAI G.S. et al. The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage. Am. J. Gastroenterol., 2004, 99 : 1306-1315.
7. MC CORMICK P.A., O'KEEFE C. Improving prognosis following a first variceal haemorrhage over four decades. Gut, 2001, 49 : 682-685.
8. BERNARD B., GRANGE J.D., KHAC E.N. et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding : a meta-analysis. Hepatology, 1999, 29 : 1655-1661.
9. NEVENS F. Review article : a critical comparison of drug therapies in currently used therapeutic strategies for variceal haemorrhage. Aliment Pharmacol. Ther., 2004, 20 (Suppl. 3) : 18-22.
10. DE FRANCHIS R. Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol., 2005, 43 : 167-176.
11. HUI A.J., SUNG J.J. Endoscopic Treatment of Upper Gastrointestinal Bleeding. Curr. Treat. Options Gastroenterol., 2005, 8 : 153-162.
12. SORBI D., GOSTOUT C.J., PEURA D. et al. An assessment of the management of acute bleeding varices : a multicenter prospective member-based study. Am. J. Gastroenterol., 2003, 98 : 2424-2434.
13. CORENS D. Health systems review : Belgium. Health Systems in Transition, 2007, 9 : 1-172.
14. TALWALKAR J.A. Cost-effectiveness of Treating Esophageal Varices. Clin. Liver Dis., 2006, 10 : 679-89, xi.
15. IMPERIALE T.F., KLEIN R.W., CHALASANI N. Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding. Hepatology, 2007, 45 : 870-8.
16. SAAB S., DEROSA V., NIETO J., DURAZO F., HAN S., ROTH B. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis : a decision analytic model. Am. J. Gastroenterol., 2003, 98 : 763-70.
17. RUSSO M.W., ZACKS S.L., SANDLER R.S., BROWN R.S. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding. Hepatology, 2000, 31 : 358-63.
18. GOTZSCHE P.C., HROBJARTSSON A. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database Syst. Rev., 2005, (1) : CD000193.
19. D'AMICO G., PAGLIARO L., BOSCH J. The treatment of portal hypertension : a meta-analytic review. Hepatology, 1995, 22 : 332-354.
20. IOANNOU G., DOUST J., ROCKEY D.C. Terlipressin for acute esophageal variceal hemorrhage. Aliment. Pharmacol. Ther., 2003, 17 : 53-64.
21. YAN B.M., LEE S.S. Emergency management of bleeding esophageal varices : drugs, bands or sleep ? Can. J. Gastroenterol., 2006, 20 : 165-170.
22. KURSTEIN P., GLUUD L.L., WILLEMANN M. et al. Agreement between reported use of interventions for liver diseases and research evidence in Cochrane systematic reviews. J. Hepatol., 2005, 43 : 984-989.
23. INGRAND P., GOURNAY J., BERNARD P. et al. Management of digestive bleeding related to portal hypertension in cirrhotic patients : A French multicenter cross-sectional practice survey. World J. Gastroenterol., 2006, 12 : 7810-7814.
24. WECHOWSKI J., CONNOLLY M., WOEHL A., TETLOW A., MC EWAN P., BURROUGHS A., CURRIE C.J., BHATT A. An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis. Curr. Med. Res. Opin., 2007, 23 : 1481-91.
25. Federaal Kenniscentrum voor de gezondheidszorg. Voorlopige richtlijnen voor farmacoeconomisch onderzoek in België, KCE reports vol. 28A (2006).
26. LAY C.S., TSAI Y.T., TEG C.Y. et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology, 1997, 25 : 1346-1350.
27. RILEY T.R. III, BHATTI A.M. Preventive strategies in chronic liver disease : part II. Cirrhosis. Am. Fam. Physician, 2001, 64 : 1735-1740.
28. GOLD M.R., SIEGEL J.E., RUSSELL L.B. Cost-effectiveness in health and medicine. New York : Oxford University Press, 1996.
29. YOUNOSSI Z.M., BOPARAI N., MC CORMICK M., PRICE L.L., GUYATT G. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am. J. Gastroenterol., 2001, 96 : 579-583.
30. FENWICK E., O'BRIEN BJ., BRIGGS A. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ., 2004, 13 : 405-415.
31. DRUMMOND M., JÖNSSON B. Moving Beyond the Drug Budget Silo Mentality in Europe. Value in Health, 2003, 6 (Suppl 1) : S74-S77.
32. LEVACHER S., LETOUMELIN P., PATERSON D., BLAISE M., LAPANDRY C., POURRIAT J.L. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet, 1995, 346 : 865-868.
33. MORALES G.F., PEREIRA LIMA J.C., HORNOS AP., MARQUES D.L., COSTA C.S., LIMA PEREIRA L., LOPES C.V., RAYMONDI R., MARRONI C.A. Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy : a randomized, placebo-controlled trial. Hepatogastroenterology, 2007, 54 : 195-200.
34. BURROUGHS A.K. Double blind RCT of 5 day octreotide versus placebo associated with sclerotherapy for trials/failures. Hepatology, 1996, 24 : 352A.
35. CARBONELL N., PAUWELS A., SERFATY L., FOURDAN O. et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology, 2004, 40 : 652-659.
36. COLLE I., VAN STEENKISTE C., GEERTS A., VAN VLIERBERGHE H. Hepatopulmonary syndrome and portopulmonary hypertension : what's new ? Acta Gastroenterol. Belg., 2007, 70 : 203-9.
37. SERSTÉ T., BOURGEOIS N., LEBREC D., EVRARD S., DEVIÈRE J., LE MOINE O. Relationship between the degree of portal hypertension and the onset of spontaneous bacterial peritonitis in patients with cirrhosis. Acta Gastroenterol. Belg., 2006, 69 : 355-60.
38. THABUT D., BERNARD-CHABERT B. Management of acute bleeding from portal hypertension. Best Pract. Res. Clin. Gastroenterol., 2007, 21 : 19-27.
39. TRIANTOS CK., GOULIS J., PATCH D. et al. An evaluation of emergency sclerotherapy of varices in randomised trials : looking the needle in the eye. Endoscopy, 2006, 38 : E74-E90
40. BANARES R., ALBILLOS A., RINCON D. et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acure variceal bleeding : a meta-analysis. Hepatology, 2002, 35 : 609-615.